Likelihood of persistent carriage of carbapenem-resistant Acinetobacter baumannii on readmission in previously identified carriers.
Acinetobacter Infections
/ diagnosis
Acinetobacter baumannii
/ drug effects
Adult
Aged
Aged, 80 and over
Anti-Bacterial Agents
/ therapeutic use
Carbapenems
/ therapeutic use
Carrier State
/ diagnosis
Drug Resistance, Bacterial
Female
Humans
Israel
Kaplan-Meier Estimate
Male
Middle Aged
Patient Readmission
/ statistics & numerical data
Journal
Infection control and hospital epidemiology
ISSN: 1559-6834
Titre abrégé: Infect Control Hosp Epidemiol
Pays: United States
ID NLM: 8804099
Informations de publication
Date de publication:
10 2019
10 2019
Historique:
pubmed:
6
8
2019
medline:
30
5
2020
entrez:
6
8
2019
Statut:
ppublish
Résumé
Patients with carbapenem-resistant Acinetobacter baumannii-positive clinical cultures during a prior hospitalization were screened using high sensitivity methods upon first readmission. Of 38 patients, 31.6% screened positive; 42% screened positive within 2 months from discharge, and 14% screened positive more than 5 months from discharge. Carriage was persistent up to 285 days.
Identifiants
pubmed: 31379306
pii: S0899823X19002101
doi: 10.1017/ice.2019.210
doi:
Substances chimiques
Anti-Bacterial Agents
0
Carbapenems
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM